Encompass Health (EHC) Q3 2026 earnings review
Encompass Health raises its profit plan, but unpaid bills rise
Encompass Health, the largest US operator of inpatient rehabilitation hospitals, grew profit much faster than revenue as staffing costs eased. Total revenue rose 9% to $1.61 billion while hospital cash profit (Adjusted EBITDA) climbed 15% because hospitals used fewer agency nurses. Chief executive Mark Tarr raised the full-year outlook for a third time, though by our math the plan points to cash profit growth slowing to about 8% in the fourth quarter.
| Inpatient hospital revenue | $1,569.1M +9.9% from a year ago |
|---|---|
| Adjusted EBITDA (hospital cash profit) | $346.6M +15.5% from a year ago |
| Profit per share, excluding one-offs | $1.52 +23.6% from a year ago |
| Full-year Adjusted EBITDA outlook | Raised $25M middle of the range: 10.8% growth |
⚖️ Verdict: 🟢 Bullish
The story got better because hospital labor efficiency beat the hardest wage comparison of the year and commercial insurers agreed to higher price increases. Those two gains allowed the company to raise its full-year profit target by $25 million despite a $10 million drop in state Medicaid supplemental payments. One caution: a billing disruption after a second-quarter software change pushed unpaid bill reserves up to 2.7% of revenue, above the annual target.
The question now is whether the company can keep collections and existing hospital volume steady as federal claim audits triple to 108 hospitals in January. Either the billing backlog clears quickly and new beds relieve full hospitals, or expanding Medicare audits and insurance denials tie up more cash in unpaid bills. Fourth-quarter bad debt reserves and year-end bed additions will tell.
🐂 Bull Case
Staffing Efficiency Lifted Margins Despite Wage Growth
Encompass Health runs inpatient rehabilitation hospitals for patients recovering from strokes, fractures and other major illnesses. A central question for the second half of 2026 was whether rising nurse and therapist pay would squeeze profit margins as the company compared against its lowest wage inflation of last year. Instead, third-quarter Adjusted EBITDA, a measure of hospital cash profit before interest, taxes and depreciation, grew 15.5% to $346.6 million.
- Salaries and benefits: 52.2% of revenue, down 0.9 percentage points from a year ago
- Hospital operating expenses: 20.2% of revenue, down 0.7 percentage points from a year ago
- Contract labor full-time equivalents: 272 workers, down 23.2% from 354 a year ago
- Employees per occupied bed (EPOB): 3.38, down from 3.42 a year ago
By our math, wages and benefits per full-time employee rose 3.8% from a year ago, right inside the company's 3.5% to 4.0% full-year plan. Even so, labor took a smaller share of revenue because hospitals replaced expensive outside agency nurses with permanent staff and treated more patients per employee. By our math, excluding a $10.0 million drop in state Medicaid supplemental payments and $1.5 million in higher provider taxes, underlying Adjusted EBITDA grew 19.3%.
What to watch: fourth-quarter salaries and benefits per employee against the full-year 3.5% to 4.0% target. Staying inside that band while agency staffing stays near 272 workers would confirm that lower staff turnover is paying for the company's internal wage increases.
New Hospital Formats and Pricing Power Lift Plan
Chief executive Mark Tarr said the hospital operator is adding beds to meet "meeting the growing demand for high-quality inpatient rehabilitation services". In the third quarter, the Birmingham-based group opened a 50-bed hospital in Norristown, Pennsylvania and added 31 beds to existing locations. That lifted total licensed beds by 3.3% from a year ago to 11,722 and drove a 5.7% increase in patient discharges.
Encompass Health also named its first small-format hospital, a 24-bed facility in Conroe, Texas scheduled for 2027 that shares management with a nearby hub hospital. Alongside steady volume, the company raised its full-year managed care pricing growth assumption to a range of 3.5% to 4.0%, up from 2.0% to 3.0% previously. Stronger commercial insurance rates helped lift net patient revenue per discharge by 4.0% to $22,543.
What to watch: fourth-quarter openings of the 60-bed Avondale, Arizona hospital and the 40-bed Cleveland, Tennessee satellite location. Opening both on time is required to hit the full-year target of eight new hospitals with 389 beds.
Positives this quarter didn't test
Two standing growth drivers from earlier quarters are not broken out in the earnings release or presentation slides and await the conference call or quarterly filing.
- Appeals of denied Medicare Advantage admissions: the release does not update how many denied patients were admitted or whether the win rate on completed appeals stayed near 89%.
- Veterans Affairs Community Care volume: the presentation raises the overall managed care pricing outlook to 3.5% to 4.0%, but does not state how fast Veterans Affairs referrals grew this quarter.
🐻 Bear Case
Software Change Disrupted Billing and Lifted Unpaid Bills
"Our value proposition and disciplined operating strategy continue to be validated, and we remain highly optimistic about the long-term prospects of our business," Tarr said. Yet internal billing execution stumbled during the quarter. Revenue reserves for bad debt, which measure patient bills the company expects to go unpaid, climbed 0.8 percentage points from a year ago to 2.7% of revenue, above the 2.0% to 2.5% full-year plan.
Encompass Health said the jump was "primarily attributable to a billing and collecting disruption issue following a system conversion in Q2 2026". Because of that collection slowdown, unpaid customer bills on the balance sheet (accounts receivable) rose 15.0% since December to $712.0 million, pulling $89.5 million of cash out of working capital over the first nine months. Management expects fourth-quarter bad debt reserves to return to 2.0% to 2.5% of revenue.
What to watch: fourth-quarter bad debt reserves as a percentage of revenue and the accounts receivable balance at year-end. A reading above 2.5% would show that the billing software problem is turning delayed collections into permanent write-offs.
Medicare Claim Audits Expand Across Seventy-Five More Hospitals
Encompass Health relies on federal Medicare for 66.3% of its revenue and private Medicare Advantage plans for another 15.7%. Both payment streams face tighter scrutiny. In September, the federal agency that runs Medicare announced it will expand its Review Choice Demonstration (RCD), a programme that audits every patient claim before or after payment unless a hospital maintains an 80% approval rate, to another billing region on January 1, 2027.
- Hospitals added to federal claim audits in January 2027: 75 facilities
- Total Encompass Health hospitals under federal claim audits in 2027: 108 of 177 facilities
- Medicare Advantage share of revenue: 15.7%, down 0.9 percentage points from a year ago
- Fourth-quarter Medicare price increase: about 2.3%, down from about 3.0% in the first three quarters
The audit expansion triples the number of Encompass Health hospitals under review from 33 to 108, covering more than three-fifths of its locations right as the annual Medicare price increase steps down to 2.3%. Meanwhile, Medicare Advantage revenue grew slower than traditional Medicare as private insurers continue to deny rehabilitation referrals.
What to watch: bad debt reserves and collection days in the first half of 2027 after the 75 additional hospitals enter the six-month review cycle. Higher claim holds would slow cash collection and lift administrative costs.
Heavy Construction Spending Leaves Existing Hospitals Capped
Discharges at hospitals open for more than a year (same-store discharges) grew 3.0%, roughly half the 5.7% total discharge growth rate, because many mature hospitals are full. To keep total volume growing, Encompass Health is spending heavily to build new facilities and expand full ones, while trimming its 2026 target for bed additions at existing hospitals to a range of 145 to 190 beds, down from 150 to 200.
Over the first nine months, the rehabilitation provider spent $617.2 million on property and equipment and another $203.7 million buying back shares, exceeding its $634.2 million of adjusted free cash flow. It bridged the gap by issuing an extra $100 million of 5.875% notes due 2034 in August, lifting total debt by $108.3 million since December to $2,599.1 million and raising full-year pre-opening costs by $2 million to a range of $20 million to $24 million.
What to watch: existing hospital bed additions in the fourth quarter against the 60 to 105 beds needed to reach the lowered full-year plan. Falling short would leave mature hospitals capacity-constrained into 2027.
👓 Other Themes
North Carolina Deregulation Triggers Permit Write-Off
In July 2026, North Carolina signed a law that "repealed the requirement of certain healthcare providers to obtain and/or maintain a certificate of need" (CON), a state permit previously required before building a hospital. Because its existing permit lost its legal exclusivity, Encompass Health recorded $2.9 million in accelerated depreciation and a $1.5 million partner offset, which it excluded from Adjusted EBITDA. The repeal lets both Encompass Health and rivals build freely in the state.
💲 Other KPIs
Cash flow after maintenance capital spending and partner payouts rose 51.2% from a year ago, rebounding from a 4.8% drop in the second quarter. The jump reflects higher operating profit and an easy comparison against the third quarter of 2025, when the hospital group paid $55.8 million of vendor bills early ahead of a software switch.
Weighted average diluted shares fell 2.5% from 102.3 million a year ago after the board doubled its buyback plan to $1.0 billion in July. The rehabilitation operator spent $57.9 million to repurchase 494,657 shares during the third quarter, bringing nine-month buybacks to $203.7 million and adding about 3 percentage points to per-share profit growth.
Outpatient therapy visits fell 16.0% from 22,361 a year ago, a steeper drop than the 0.7% increase in the second quarter and the 15.5% decline in the fourth quarter of 2025. The US company continues to close non-core outpatient clinics to focus staff and space on higher-paying overnight hospital stays.
🔮 Guidance
Raised. The middle of the full-year sales plan moved up by $25 million to $6,475 million, or 9.1% growth for the year. By our math, that leaves $1,681.5 million for the fourth quarter, or 8.9% growth from a year ago, matching the third quarter's 8.9% pace. It is the third raise this year: +$7.5M, +$27.5M, +$25.0M.
Raised. The middle of the hospital cash profit target rose $25 million to $1,405 million, or 10.8% full-year growth. By our math, the outlook leaves $361.6 million for the fourth quarter, or 7.8% growth from a year ago, down from 15.5% in the third quarter as Medicare pricing steps down to 2.3% and hospital pre-opening costs rise. It is the third raise this year, and each was larger: +$5M, +$15M, +$25M.
Raised. Management lifted the middle of the per-share profit forecast by $0.165 to $6.30, representing 15.6% growth for the year. By our math, that implies $1.63 per share in the fourth quarter, or 11.6% growth from a year ago, compared with 23.6% in the third quarter. It is the third raise of 2026: +$0.045, +$0.135, +$0.165.
Raised at the bottom end. The middle of the cash flow range moved up $5 million to $817.5 million, roughly flat against $817.9 million in 2025. By our math, that implies $183.3 million in the fourth quarter, down 22.1% from a year ago because full-year cash tax payments were raised by $20 million to a range of $200 million to $220 million.
❓ Key Questions
What caused the second-quarter software change to disrupt billing?
Bad debt reserves rose to 2.7% of revenue and unpaid customer bills climbed by $92.8 million since December. Investors need to know which billing system changed in the second quarter, whether claims were rejected or just delayed, and how much cash remains uncollected.
How are Medicare Advantage appeals performing ahead of expansion?
Management previously promised to decide by the end of 2026 whether to roll out its admit-and-appeal programme across all hospitals. The release did not update the 298 admitted patients or the 89% appeal win rate disclosed last quarter.
Why will seventy-five hospitals enter Medicare claim audits in January?
Federal auditors are expanding pre-claim and post-payment reviews to Jurisdiction JJ on January 1, 2027, bringing 108 of 177 hospitals under audit. Management has not quantified the extra staffing or administrative cost needed to handle three times as many audited facilities.
Why did the existing hospital bed addition target drop?
Encompass Health trimmed its 2026 target for bed additions at existing hospitals to 145 to 190 beds from 150 to 200, with only 85 added through September. With many mature hospitals running above 90% occupancy, delays in adding beds cap existing hospital growth.